The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 6
- 6 new
- Median first-year cost
- $1,999,679
- $12,154,590 in all
- Institutions
- 6
- 6 contact PIs
- Patents
- 2
- from 2 funded projects
Awards by fiscal year
Fiscal years 2014 to 2026.
Most frequent institutions
- BATTELLE PACIFIC NORTHWEST LABORATORIES1
- HARVARD UNIVERSITY1
- INDIANA UNIVERSITY INDIANAPOLIS1
- UNIVERSITY OF FLORIDA1
- UNIVERSITY OF TENNESSEE HEALTH SCI CTR1
and 1 other institution
Most frequent study sections
- Special Emphasis Panel (ZDK1 GRB-S (O4))6
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2014 | Regulatory Networks and Biomarkers of Beta-cell Dysfunction and Apoptosis1UC4DK104167-01 | Kulkarni, Rohit N.Mathews, Clayton EQian, Wei-Jun | BATTELLE PACIFIC NORTHWEST LABORATORIES, WA | First-year cost $2,621,408 | Study section ZDK1 |
| FY2014 | Epigenetic, Protein, and Cellular Biomarkers of Beta Cell Function in T1D1UC4DK104205-01 | Herold, Kevan C | YALE UNIVERSITY, CT | First-year cost $2,496,787 | Study section ZDK1 |
| FY2014 | Biomarkers Of Beta Cell Stress In Type 1 Diabetes (BetaMarker)1UC4DK104166-01 | Eizirik, Decio LaksEvans-Molina, CarmellaMetz, Thomas OMirmira, Raghavendra GNadler, Jerry L. | INDIANA UNIVERSITY INDIANAPOLIS, IN | First-year cost $2,401,653 | Study section ZDK1 |
| FY2014 | Defining Islet Heterogeneity Using Single Islet Transcriptomics1UC4DK104155-01 | Campbell-Thompson, MarthaGerling, Ivan C | UNIVERSITY OF TENNESSEE HEALTH SCI CTR, TN | First-year cost $1,597,704 | Study section ZDK1 |
| FY2014 | Biomarkers for Diabetes Using Stem Cell-Derived Beta Cells1UC4DK104159-01 | Melton, Douglas A | HARVARD UNIVERSITY, MA | First-year cost $1,593,083 | Study section ZDK1 |
| FY2014 | Non-Invasive Diagnosis of Human Beta Cell Damage and Death1UC4DK104216-01 | Schatz, Desmond Arthur | UNIVERSITY OF FLORIDA, FL | First-year cost $1,443,955 | Study section ZDK1 |
Patents from its funded projects
2 patents name 2 of the 6 funded projects.
- US 11,389,106 (opens the patent at USPTO, a PDF, in a new tab)Non-Invasive Diagnostic Biomarker for Pancreatic Islet PopulationsGranted July 19, 2022 to University of Florida Research Foundation, Inc. and The Johns Hopkins UniversityUC4DK104155 · UNIVERSITY OF TENNESSEE HEALTH SCI CTR, TN
- US 10,738,343 (opens the patent at USPTO, a PDF, in a new tab)Extracellular Vesicle Ribonucleic Acid (RNA) Cargo as a Biomarker of Hyperglycaemia and Type 1 DiabetesGranted August 11, 2020 to THE TRUSTEES OF INDIANA UNIVERSITYUC4DK104166 · INDIANA UNIVERSITY INDIANAPOLIS, IN
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-13-0.3.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.